1 document found, page 1 of 1
Sort by
Issue Date
Predictors of ACEI/ARB therapy in patients with hypertrophic cardiomyopathy : r...
Martins, E.; Lebreiro, A.; Sousa, C.; Leite, S.; Sousa, A.; Belo, A.; Brito, Dulce; Cardim, N.Introduction: Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) are not considered disease-modifying drugs in hypertrophic cardiomyopathy (HCM) and their use is usually dependent on other clinical indications. Few data exist about the use of ACEI/ARB in HC in the real world, particularly in patients with intraventricular obstruction. Objective: In this study, we sought t...
Date: 2018
|
Origin: Repositório da Universidade de Lisboa